cbdMD (YCBD) Net Margin (2016 - 2025)

cbdMD (YCBD) reported Net Margin of 6.47% for Q4 2025, up 1280.0% on a YoY basis from 0.47% in Q4 2024, and up 55.08% sequentially from 14.4% in Q3 2025.

cbdMD (YCBD) Net Margin (2016 - 2025) Analysis & Trends

cbdMD (YCBD) has 10 years of Net Margin data on file, last reported at 6.47% in Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 1280.0% year-over-year to 6.47%; the trailing twelve-month figure through Dec 2025 stood at 19.45% (up 1459.0% YoY), and the FY2025 full-year result was 22.8%, up 1587.0% from the prior year.
  • Net Margin climbed to 6.47% in Q4 2025, from 14.4% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 8.61% in Q2 2021 to a low of 379.79% in Q2 2022.
  • A 5-year average of 85.69% and a median of 39.71% in 2021 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin plunged 38839 bps in 2022 and surged 33451 bps in 2023, its largest moves.
  • Tracing YCBD's Net Margin over 5 years: stood at 204.54% in 2021, then soared by 61 bps to 79.43% in 2022, then surged by 53 bps to 37.15% in 2023, then surged by 48 bps to 19.27% in 2024, then jumped by 66 bps to 6.47% in 2025.
  • Business Quant data shows YCBD's Net Margin at 6.47% in Q4 2025, 14.4% in Q3 2025, and 26.67% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn -6.47%

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.47%
Sep 30, 2025 -14.40%
Jun 30, 2025 -26.67%
Mar 31, 2025 -31.19%
Dec 31, 2024 -19.27%
Sep 30, 2024 -23.12%
Jun 30, 2024 -10.45%
Mar 31, 2024 -91.65%
Dec 31, 2023 -37.15%
Sep 30, 2023 -346.72%
Jun 30, 2023 -45.28%
Mar 31, 2023 -37.46%
Dec 31, 2022 -79.43%
Sep 30, 2022 -163.19%
Jun 30, 2022 -379.79%
Mar 31, 2022 -58.76%
Dec 31, 2021 -204.54%
Sep 30, 2021 -41.96%
Jun 30, 2021 8.61%
Mar 31, 2021 -104.92%